More Than Reducing Early Fistula Thrombosis Is Required: Lessons From the Dialysis Access Consortium Clopidogrel Fistula Study

American Journal of Kidney Diseases

Volumn 52, Issue 5, 2008, Pages 834-838

  Lok, Charmaine E ^a   Moist, Louise ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO; SULFINPYRAZONE; TICLOPIDINE;

ARTERIOVENOUS FISTULA; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; DIALYSIS; EDITORIAL; HEMODIALYSIS; HUMAN; LOADING DRUG DOSE; PHYSICAL EXAMINATION; PREOPERATIVE EVALUATION; THROMBOSIS; TREATMENT OUTCOME; VASCULAR ACCESS;

EID: 54149115499     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.09.005     Document Type: Editorial

References (29)

1. Clinical Performance Measures (CPM) Project: Phase III ESRD CPM 04012008 Final. http://www.cms.hhs.gov/CPMProject/Downloads/ESRDPhaseIIICPM04012008Final.pdf Accessed June 1, 2008
2. Moist L.M., Chang S.H., Polkinghorne K.R., and McDonald S.P. Trends in hemodialysis vascular access from the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 2000 to 2005. Am J Kidney Dis 50 (2007) 612-621
3. Moist LM, Trpeski L, Na Y, Lok CE: Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol 2008 (in press)
4. US Renal Data System. USRDS 2006 Annual Data Report: Atlas of endstage renal disease in the United States. In Costs of CKD and ESRD: Vascular Access (2006), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Betheseda, MD
5. Lok C.E. Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol 2 (2007) 1043-1053
6. Lacson Jr. E., Lazarus J.M., Himmelfarb J., et al. Balancing Fistula First with Catheters Last. Am J Kidney Dis 50 (2007) 379-395
7. Lok C.E., Allon M., Moist L., et al. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 17 (2006) 3204-3212
8. Dember L.M., Beck G.J., Allon M., et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 299 (2008) 2164-2171
9. Andrassy K., Malluche H., Bornefeld H., et al. Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study. Klin Wochenschr 52 (1974) 348-349
10. Michie D., and Wombolt D. Use of sulfinpyrazone to prevent thrombus formation in arteriovenous fistulas and bovine grafts of patients on chronic hemodialysis. Curr Ther Res 22 (1977) 196-204
11. Albert E. Prevention of early thrombus formation in arteriovenous fistulae. Dial Transplant 10 (1981) 167C-167D
12. Grontoft K.C., Mulec H., Gutierrez A., and Olander R. Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis. Scand J Urol Nephrol 9 (1985) 55-57
13. Fiskerstrand C.E., Thompson I.W., Burnet M.E., et al. Double-blind randomized trial of the effect of ticlopidine in arteriovenous fistulas for hemodialysis. Artif Organs 9 (1985) 61-63
14. Janicki K., Dmoszynska A., Janicka L., et al. Influence of antiplatelet drugs on occlusion of arteriovenous fistula in uraemic patients. Int Urol Nephrol 24 (1992) 83-89
15. Janicki K., Janicka L., Dmoszynska A., Marczewski K., and Smarz I. Effects of ticoplidine on platelet activity and occlusion of arteriovenous fistulas in IPD patients. Dial Transplant 23 (1994) 576-579
16. Grontoft K.C., Larsson R., Mulec H., et al. Effects of ticlopidine in AV-fistula surgery in uremia. Fistula Study Group. Scand J Urol Nephrol 32 (1998) 276-283
17. Dember L.M., Kaufman J.S., Beck G.J., et al. Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial. Clin Trials 2 (2005) 413-422
18. Ashley I: Personal communication, July 2008. FAVOURED Trial: Fish oil and aspirin in vascular access outcomes in renal disease
19. Hasegawa T., Elder S.J., Bragg-Gresham J.L., et al. Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol 3 (2008) 1373-1378
20. Peterson W.J., Barker J., and Allon M. Disparities in fistula maturation persist despite preoperative vascular mapping. Clin J Am Soc Nephrol 3 (2008) 437-441
21. Korten E., Toonder I.M., Schrama Y.C., et al. Dialysis fistulae patency and preoperative diameter ultrasound measurements. Eur J Vasc Endovasc Surg 33 (2007) 467-471
22. Huber T.S., Ozaki C.K., Flynn T.C., et al. Prospective validation of an algorithm to maximize native arteriovenous fistulae for chronic hemodialysis access. J Vasc Surg 36 (2002) 452-459
23. Falk A. Maintenance and salvage of arteriovenous fistulas. J Vasc Interv Radiol 17 (2006) 807-813
24. Rooijens P.P., Burgmans J.P., Yo T.I., et al. Autogenous radial-cephalic or prosthetic brachial-antecubital forearm loop AVF in patients with compromised vessels?. A randomized, multicenter study of the patency of primary hemodialysis access. J Vasc Surg 42 (2005) 481-486
25. Biuckians A., Scott E.C., Meier G.H., et al. The natural history of autologous fistulas as first-time dialysis access in the KDOQI era. J Vasc Surg 47 (2008) 415-421
26. Slayden GC, Spergel L, Jennings WC: Secondary arteriovenous fistulas; converting prosthetic AV grafts to autogenous dialysis access. Semin Dial 2008 (in press)
27. Vascular Access 2006 Work Group: Clinical practice guidelines for vascular access. Am J Kidney Dis 48 (2006) S176-S247
28. Polkinghorne K.R., Lau K.K., Saunder A., et al. Does monthly native arteriovenous fistula blood-flow surveillance detect significant stenosis-a randomized controlled trial. Nephrol Dial Transplant 21 (2006) 2498-2506
29. Moist L.M., Churchill D.N., House A.A., et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol 14 (2003) 2645-2653